Joe Muldoon, FAST BioMedical CEO
Joe Muldoon is the Chief Executive Officer of FAST BioMedical, a privately held, medical technology company in late stage clinical trials located in Carmel, Indiana. FAST has developed technology for quantifying blood volume and kidney function. This is a well validated unmet medical need, meeting the FDA‘s requirements for a rare Expedited Review. Joe leverages over 30 years of experience, from technology start-ups to publicly traded multi-national companies. His expertise is in culture building and value creation from inception, thru capitalization, commercialization and exit. He has worked with many high-growth entrepreneurial companies as a Board advisor, investor, and CEO. He previously served as an Entrepreneur in Residence of the Indiana Venture Center and President of Brightpoint North America, a $750MM Publicly Traded company. (NASDAQ:CELL – sold to Ingram Micro) Mr. Muldoon has a Bachelor of Science in Business from Indiana University’s Kelley School of Business, where he is a frequent panelist and speaker for MBA programs.
He serves on the Boards of Confluence Pharmaceuticals, The Kidney Health Initiative (FDA), Heart Reach Carmel and FAST BioMedical. He previously served on the Boards of Trust Bearer Labs (sold to Verisign) TGX Medical, Jameson, Inc., Venture Club of Indiana, and InfoDynamics.